Copyright Reports & Markets. All rights reserved.

Global Chronic Obstructive Pulmonary Disease Devices Sales Market (Sales,Revenue and competitors Analysis of Major Market) from 2014-2026

Buy now

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Chronic Obstructive Pulmonary Disease Devices Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Oxygen Therapy Systems
      • 2.1.2 Blood Gas Monitoring Systems
      • 2.1.3 Airway Management Accessories
      • 2.1.4 Spirometry Testing Products
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Oxygen Therapy Systems
      • 2.2.2 Blood Gas Monitoring Systems
      • 2.2.3 Airway Management Accessories
      • 2.2.4 Spirometry Testing Products

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospital
      • 3.1.2 ASCs
      • 3.1.3 Home Care

    4 Manufacturers Profiles/Analysis

    • 4.1 Covidien LTD
      • 4.1.1 Covidien LTD Profiles
      • 4.1.2 Covidien LTD Product Information
      • 4.1.3 Covidien LTD Chronic Obstructive Pulmonary Disease Devices Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Covidien LTD SWOT Analysis
    • 4.2 Abbott Laboratories
      • 4.2.1 Abbott Laboratories Profiles
      • 4.2.2 Abbott Laboratories Product Information
      • 4.2.3 Abbott Laboratories Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Abbott Laboratories SWOT Analysis
    • 4.3 Cardinal Health, Inc.
      • 4.3.1 Cardinal Health, Inc. Profiles
      • 4.3.2 Cardinal Health, Inc. Product Information
      • 4.3.3 Cardinal Health, Inc. Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Cardinal Health, Inc. SWOT Analysis
    • 4.4 Chart Industries, Inc.
      • 4.4.1 Chart Industries, Inc. Profiles
      • 4.4.2 Chart Industries, Inc. Product Information
      • 4.4.3 Chart Industries, Inc. Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Chart Industries, Inc. SWOT Analysis
    • 4.5 AirSep Corporation
      • 4.5.1 AirSep Corporation Profiles
      • 4.5.2 AirSep Corporation Product Information
      • 4.5.3 AirSep Corporation Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 AirSep Corporation SWOT Analysis
    • 4.6 Teleflex Medical, Inc.
      • 4.6.1 Teleflex Medical, Inc. Profiles
      • 4.6.2 Teleflex Medical, Inc. Product Information
      • 4.6.3 Teleflex Medical, Inc. Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Teleflex Medical, Inc. SWOT Analysis
    • 4.7 Masimo Corporation
      • 4.7.1 Masimo Corporation Profiles
      • 4.7.2 Masimo Corporation Product Information
      • 4.7.3 Masimo Corporation Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Masimo Corporation SWOT Analysis
    • 4.8 F. Hoffmann-La Roche LTD
      • 4.8.1 F. Hoffmann-La Roche LTD Profiles
      • 4.8.2 F. Hoffmann-La Roche LTD Product Information
      • 4.8.3 F. Hoffmann-La Roche LTD Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 F. Hoffmann-La Roche LTD SWOT Analysis
    • 4.9 Siemens AG
      • 4.9.1 Siemens AG Profiles
      • 4.9.2 Siemens AG Product Information
      • 4.9.3 Siemens AG Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Siemens AG SWOT Analysis
    • 4.10 Smiths Medical, Inc.
      • 4.10.1 Smiths Medical, Inc. Profiles
      • 4.10.2 Smiths Medical, Inc. Product Information
      • 4.10.3 Smiths Medical, Inc. Chronic Obstructive Pulmonary Disease DevicesSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Smiths Medical, Inc. SWOT Analysis
    • 4.11 Pall Corporation
    • 4.12 Philips Healthcare, Inc.
    • 4.13 Radiometer Medical AS
    • 4.14 Spirometrics, Inc.
    • 4.15 Welch Allyn Holdings, Inc.

    5 Market Performance for Manufacturers

    • 5.1 Global Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Chronic Obstructive Pulmonary Disease Devices Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Chronic Obstructive Pulmonary Disease Devices Market Assessment by Regions (2014-2020)

    • 7.1 Global Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Chronic Obstructive Pulmonary Disease Devices Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Chronic Obstructive Pulmonary Disease Devices Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Chronic Obstructive Pulmonary Disease Devices Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Hospital Industry
    • 11.2 ASCs Industry
    • 11.3 Home Care Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Chronic Obstructive Pulmonary Disease Devices Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Chronic Obstructive Pulmonary Disease Devices Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Oxygen Therapy Systems
      • 12.2.3 Blood Gas Monitoring Systems
      • 12.2.4 Airway Management Accessories
      • 12.2.5 Spirometry Testing Products
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospital
      • 12.3.3 ASCs
      • 12.3.4 Home Care
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Chronic Obstructive Pulmonary Disease Devices Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Chronic Obstructive Pulmonary Disease Devices Gross Profit Trend 2021-2026

    13 Conclusion

    According to XYZResearch study, over the next five years the Chronic Obstructive Pulmonary Disease Devicesmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Chronic Obstructive Pulmonary Disease Devicesbusiness.
    Chronic Obstructive Pulmonary Disease Devices market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
    Sales forecast by type/application from 2021-2026
    Industry chain, downstream and upstream information is also included.
    World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
    Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
    XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

    This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Chronic Obstructive Pulmonary Disease Devices for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Chronic Obstructive Pulmonary Disease Devices market competition by top manufacturers/players, with Chronic Obstructive Pulmonary Disease Devices sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Covidien LTD
    Abbott Laboratories
    Cardinal Health, Inc.
    Chart Industries, Inc.
    AirSep Corporation
    Teleflex Medical, Inc.
    Masimo Corporation
    F. Hoffmann-La Roche LTD
    Siemens AG
    Smiths Medical, Inc.
    Pall Corporation
    Philips Healthcare, Inc.
    Radiometer Medical AS
    Spirometrics, Inc.
    Welch Allyn Holdings, Inc.
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oxygen Therapy Systems
    Blood Gas Monitoring Systems
    Airway Management Accessories
    Spirometry Testing Products
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Chronic Obstructive Pulmonary Disease Devices for each application, including
    Hospital
    ASCs
    Home Care

    Feel free to let me know if you have any special requirements.

    Buy now